Literature DB >> 17283865

The association between morning hypertension and metabolic syndrome in hypertensive patients.

Shinji Tamaki1, Yasuyuki Nakamura, Tomohide Yoshino, Yuichi Matsumoto, Yasuhiro Tarutani, Tabito Okabayashi, Takeshi Kawashima, Minoru Horie.   

Abstract

Morning hypertension (MHT) and metabolic syndrome (MS) have been reported as important risk factors for stroke and cardiovascular events. We investigated the prevalence of MHT and MS among hypertensive patients in our outpatient clinic from June to August, 2005. We studied 181 hypertensive patients (91 men and 90 women) in our outpatient clinic using home-use electronic sphygmomanometers. Seventy-nine of these 181 patients (43.6%) demonstrated MHT, defined as systolic blood pressure (SBP) > or = 135 mmHg in the morning. Only 48.1% of the patients demonstrated normal SBP both at the clinic and in the morning at home, whereas 72.9% of the patients demonstrated normal diastolic blood pressure (DBP) under the same conditions. Sixty-one patients (33.7%) had MS, and 34 patients had both MHT and MS. Twenty-seven of the 102 patients (26.5%) without MHT had MS. The frequency of MS was significantly higher among those with MHT than those without MHT (p = 0.019). Multiple logistic regression analysis including smoking, alcohol consumption, sex, and age as confounding factors showed significant association between MHT and MS (odds ratio: 1.99; 95% confidence interval: 1.04-3.80; p = 0.039). In conclusion, although 1 year has passed since the JSH 2004 guidelines, 43.6% of our patients still showed MHT, and there was a significantly higher prevalence of MS among those with MHT. Our results suggest the need for a more vigorous intervention for controlling BP.

Entities:  

Mesh:

Year:  2006        PMID: 17283865     DOI: 10.1291/hypres.29.783

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  7 in total

Review 1.  The Role of Circadian Rhythms in the Hypertension of Diabetes Mellitus and the Metabolic Syndrome.

Authors:  Björn Lemmer; Henrik Oster
Journal:  Curr Hypertens Rep       Date:  2018-05-05       Impact factor: 5.369

2.  Morning hypertension in treated hypertensives: baseline characteristics and clinical implications.

Authors:  Ju-Hee Lee; Jang-Whan Bae; Jung Bae Park; Chang Gyu Park; Ho-Joong Youn; Dong Ju Choi; Young Keun Ahn; Joon-Han Shin; Se-Joong Rim; Jang-Ho Bae; Dong-Woon Kim
Journal:  Korean Circ J       Date:  2011-12-31       Impact factor: 3.243

3.  Enhanced blood pressure-lowering effect of olmesartan in hypertensive patients with chronic kidney disease-associated sympathetic hyperactivity: HONEST study.

Authors:  Kazuomi Kario; Ikuo Saito; Toshio Kushiro; Satoshi Teramukai; Yoshihiro Mori; Katsutoshi Hiramatsu; Fumiaki Kobayashi; Kazuyuki Shimada
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-05-31       Impact factor: 3.738

Review 4.  Characteristics and control of the 24-hour ambulatory blood pressure in patients with metabolic syndrome.

Authors:  Jian-Feng Huang; Yan Li; Jinho Shin; Yook-Chin Chia; Apichard Sukonthasarn; Yuda Turana; Chen-Huan Chen; Hao-Min Cheng; Arieska Ann Soenarta; Jam Chin Tay; Tzung-Dau Wang; Kazuomi Kario; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-25       Impact factor: 3.738

5.  Prognostic value of home blood pressure monitoring in patients under antihypertensive treatment.

Authors:  Jessica Barochiner; Lucas S Aparicio; Rocío Martínez; José Boggia
Journal:  J Hum Hypertens       Date:  2022-09-26       Impact factor: 2.877

Review 6.  Management of morning hypertension: a consensus statement of an Asian expert panel.

Authors:  Ji-Guang Wang; Kazuomi Kario; Chen-Huan Chen; Jeong-Bae Park; Satoshi Hoshide; Yong Huo; Hae-Young Lee; Yan Li; Masaki Mogi; Masanori Munakata; Sungha Park; Dingliang Zhu
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-16       Impact factor: 3.738

7.  Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.

Authors:  Jean-Jacques Mourad; Dulce Lameira; Pierre-Jean Guillausseau
Journal:  Vasc Health Risk Manag       Date:  2008
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.